MedPath

Tranexamic Acid

These highlights do not include all the information needed to use TRANEXAMIC ACID INJECTION safely and effectively. See full prescribing information for TRANEXAMIC ACID INJECTION. TRANEXAMIC ACID INJECTION, for intravenous use Initial U.S. Approval: 1986

Approved
Approval ID

81916afc-f83a-4bba-a810-17393980e27e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 1, 2021

Manufacturers
FDA

American Regent, Inc.

DUNS: 002033710

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

tranexamic acid

PRODUCT DETAILS

NDC Product Code0517-0960
Application NumberANDA201885
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateMarch 1, 2021
Generic Nametranexamic acid

INGREDIENTS (2)

TRANEXAMIC ACIDActive
Quantity: 100 mg in 1 mL
Code: 6T84R30KC1
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
Tranexamic Acid - FDA Approval | MedPath